지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
Background: Liver cirrhosis causes substantial socio-economic burden and is one of the major severe liver diseases in Korea. Nonetheless, there is only a few studies that analyzes disease burden of liver cirrhosis in Korea. Such study must be carried out due to its increasing need from the invention of new drugs for chronic hepatitis and demand for cost-effectiveness analyses. Methods: Patient sample data with ensured representativeness was analyzed retrospectively to compare the medical costs and uses for patients with compensated cirrhosis and decompensated cirrhosis. Patient claims data that include K74 and K703 from the year of 2014 were selected. Within the selected data, decompensated cirrhosis patient was identified if complications such as ascites (R18), encephalopathy (B190), hepatic failure (K72), peritonitis (K65), or esophageal varices (I85) were included, and they were compared to compensated cirrhosis patients. Results: 6,565 patients were included in the analysis. The average cost per patient was 6,471,020 (SD 8,848,899) KRW and 2,173,203 (4,220,942) KRW for decompensated cirrhosis and compensated cirrhosis, respectively. For inpatients, the average hospitalized days was 38.0 (56.4) days and 27.2 (57.2) days for decompensated cirrhosis and compensated cirrhosis, respectively. For outpatients, the average number of visits was 8.7 (9.1) days and 5.3 (7.5) days for compensated cirrhosis and decompensated cirrhosis, respectively. Conclusion: Compared to compensated cirrhosis patients, decompensated cirrhosis patients had higher costs, especially for hospitalization, injection, examination, and drugs administrated within medical institutions.
목차
등록된 정보가 없습니다.
참고문헌 (32)
참고문헌 신청
The Korean Association for the Study of the Liver and liver cirrhosis clinical research center / Clinical Practice Guideline for Liver Cirrhosis
The Korean Association for the Study of the Liver / 2013 / White Paper on Liver Diseases in Korea / The Korean Association for the Study of the Liver
HIRA / Healthcare Bigdata Hub
Abergel A / 2016 / Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012(The HEPC-LONE study) / Clin Res Hepatol Gastroenterol 40(3):340~348
Kieran JA / 2015 / Hepatitis C in the era of directacting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study / BMC infect Dis 15:471
The Korean Association for the Study of the Liver / 2013 / White Paper on Liver Diseases in Korea / The Korean Association for the Study of the Liver
HIRA / Healthcare Bigdata Hub
Abergel A / 2016 / Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012(The HEPC-LONE study) / Clin Res Hepatol Gastroenterol 40(3):340~348
Kieran JA / 2015 / Hepatitis C in the era of directacting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study / BMC infect Dis 15:471
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Patients with Liver Cirrhosis
대한외과학회 학술대회 초록집
2021 .11
-
Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea
Journal of Korean Medical Science
2020 .01
-
Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea
Clinical and Molecular Hepatology
2020 .01
-
Are there differences in risk factors, microbial aspects, and prognosis of cellulitis between compensated and decompensated hepatitis C virus-related cirrhosis?
Clinical and Molecular Hepatology
2019 .01
-
A need for patient-centered care in managing patients with liver cirrhosis
Clinical and Molecular Hepatology
2021 .01
-
Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol
Journal of Korean Medical Science
2021 .01
-
Complications Requiring Hospital Admission and Causes of In-Hospital Death over Time in Alcoholic and Nonalcoholic Cirrhosis Patients
Gut and Liver
2016 .01
-
Is partial hepatectomy a curable treatment option for hepatocellular carcinoma accompanied by cirrhosis? A meta-analysis and cure model analysis
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .02
-
상세불명의 비대상성 간경변증 환자 치험 1례
대한한방내과학회지
2020 .01
-
Prognostic indicators and risk factors for the in-hospital mortality rate of patients with cirrhosis
International Journal of Gastrointestinal Intervention
2024 .07
-
Outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms in patients with liver cirrhosis
Clinical Endoscopy
2022 .05
-
The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
Clinical and Molecular Hepatology
2021 .01
-
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
Clinical and Molecular Hepatology
2023 .01
-
Changes in the epidemiology and management of bacterial infections in cirrhosis
Clinical and Molecular Hepatology
2021 .01
-
Combined Effect of Granulocyte-Colony-Stimulating Factor-Induced Bone Marrow-Derived Stem Cells and Red Ginseng in Patients with Decompensated Liver Cirrhosis (Combined Effect of G-CSF and Red Ginseng in Liver Cirrhosis)
대한한의학회지
2016 .12
-
Management of alcoholic hepatitis and cirrhosis
한국간담췌외과학회 학술대회지
2016 .04
-
Classification of Liver cirrhosis via data mining algorithm: A new tool to detect disease
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Reply to Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
Clinical and Molecular Hepatology
2023 .01
-
Parenting stress: psychological condition of parents with children with cirrhosis of the liver
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
간경변의 진단
대한의사협회지
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0